Numerous studies have demonstrated the critical role of NF‐κB signaling in cognitive impairment associated with diseases such as multiple sclerosis, attention deficit disorder, Parkinson's disease, and diabetes‐related cognitive dysfunction. Here, NFKB1 is linked to multiple sclerosis.